Symlin pramlintide acetate: Post-marketing study data

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN), San Diego, Calif. Product: Symlin pramlintide acetate Business: Endocrine Molecular target: Amylin receptor Description: Synthetic amylin analog Indication...